Streetbeat News

Earnings

BCBP

BCB Bancorp (NASDAQ:BCBP) reported Q1 2024 earnings of $0.32 per share, missing the consensus estimate of $0.34 by 5.88%.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 8:17 pm

PKBK

Parke Bancorp (NASDAQ:PKBK) reported a significant decrease in its quarterly earnings, with EPS dropping to $0.51 from $0.92 YoY, marking a 44.57% decline.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 8:17 pm

MRVL

Whales have shown a bearish stance on Marvell Tech (NASDAQ:MRVL), with 61% of detected trades being bearish. The options trading activity indicates a focus on a price band between $50.0 and $90.0. Despite this, analysts have set an average target price of $89.8 for MRVL, with mixed ratings from various firms. The stock is currently down by -4.77%, with a trading volume of 14,439,124 and an RSI suggesting it may be approaching oversold territory. The next earnings report is due in 34 days.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 8:16 pm

PRK

Park National Corporation (AMEX:PRK) reported Q1 2024 earnings of $2.17 per share, surpassing the analyst consensus estimate of $1.83 by 18.58%.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 8:16 pm

ARM

ASML

FTQI

IRBO

NVDA

SMCI

TSM

Arm Holdings Plc (NASDAQ:ARM) shares dropped after Exane BNP Paribas downgraded the stock from Outperform to Neutral with a $100 price target. The semiconductor sector is under pressure, with poor earnings from ASML Holdings N.V. (NASDAQ:ASML) and a reduced outlook from Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM). Nvidia Corporation (NASDAQ:NVDA) and Super Micro Computer, Inc. (NASDAQ:SMCI) also saw significant declines. Investors can access Arm through ETFs like FTQI and IRBO.

Portfolio Pulse from Erica Kollmann

April 19, 2024 | 8:02 pm

IART

Integra LifeSciences announced the rescheduling of its Q1 financial results conference call, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 7:56 pm

SYK

Stryker (NYSE:SYK) has seen significant options trading activity, with a bearish sentiment prevailing among traders. Analysis of recent trades revealed 75% bearish and 25% bullish positions, with notable activity in puts over calls. The options market is indicating a price target range of $320.0 to $340.0 for Stryker. Despite this, analysts remain positive on SYK, with an average price target of $390.5 from four professional analysts. The current market status shows SYK's price at $325.58, with indicators suggesting it may be oversold. Earnings are expected in 11 days.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 7:46 pm

KMI

Kinder Morgan's stock is trading higher following the announcement of its Q1 earnings and an increase in its quarterly dividend.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 7:30 pm

CAMT

KLAC

MCHP

MPWR

QCOM

TER

Semiconductor and chip stocks are trading lower due to pressure from ASML and TSMC's earnings and market uncertainty caused by Iran-Israel tensions. Stocks like CAMT, KLAC, MCHP, MPWR, QCOM, and TER are affected.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 7:24 pm

BMY

Financial analysis reveals a bearish sentiment in the options market for Bristol-Myers Squibb (NYSE:BMY), with 75% of trades showing bearish tendencies. The analysis of unusual trades indicates a targeted price range of $43.0 to $55.0. Significant options trades include both puts and calls, with a notable volume and open interest within this price range. Bristol-Myers Squibb, a leader in immuno-oncology, shows a 1.38% increase in stock price to $48.97, with an upcoming earnings release in 6 days. Analysts, including one from Wells Fargo, set an average target price of $52.0.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 7:16 pm